NCT07116213View on ClinicalTrials.gov

Clinical Research on Moderately Hypofractionated Adaptive Postoperative Radiotherapy for High-Risk Endometrial Cancer

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

June 30, 2029

Study Completion Date

December 30, 2030

Conditions
Endometrial CancerHypofractionated DoseRadiotherapy, AdjuvantSide EffectsSurvival , Tumor
Interventions
RADIATION

Moderately Hypofractionated Adaptive Radiotherapy

Moderately Hypofractionated Adaptive Postoperative Radiotherapy

Trial Locations (1)

100730

RECRUITING

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Xiaorong Hou

OTHER

NCT07116213 - Clinical Research on Moderately Hypofractionated Adaptive Postoperative Radiotherapy for High-Risk Endometrial Cancer | Biotech Hunter | Biotech Hunter